{"id":16858,"date":"2025-07-01T10:45:48","date_gmt":"2025-07-01T10:45:48","guid":{"rendered":"https:\/\/itbusinesstoday.com\/?p=16858"},"modified":"2025-07-01T10:45:48","modified_gmt":"2025-07-01T10:45:48","slug":"phc-secures-exclusive-rights-to-maxcyte-expert-in-japan","status":"publish","type":"post","link":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/phc-secures-exclusive-rights-to-maxcyte-expert-in-japan\/","title":{"rendered":"PHC\u3001MaxCyte ExPERT\u306e\u65e5\u672c\u306b\u304a\u3051\u308b\u72ec\u5360\u8ca9\u58f2\u6a29\u3092\u7372\u5f97"},"content":{"rendered":"

PHC\u30db\u30fc\u30eb\u30c7\u30a3\u30f3\u30b0\u30b9\u682a\u5f0f\u4f1a\u793e\u306e\u5b50\u4f1a\u793e\u3067\u3042\u308bPHC\u30b3\u30fc\u30dd\u30ec\u30fc\u30b7\u30e7\u30f3\u306e\u30d0\u30a4\u30aa\u30e1\u30c7\u30a3\u30ab\u30eb\u4e8b\u696d\u90e8\u306f\u3001MaxCyte, Inc.\u3068\u3001\u65e5\u672c\u306b\u304a\u3051\u308b\u300cMaxCyte ExPERT\u300d\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306e\u8ca9\u58f2\u306b\u95a2\u3059\u308b\u72ec\u5360\u5951\u7d04\u3092\u7de0\u7d50\u3057\u305f\u3068\u767a\u8868\u3057\u305f\u3002 \u30b7\u30f3\u30ac\u30dd\u30fc\u30eb\u3067\u306f\u3001PHCHD\u306e\u5b50\u4f1a\u793e\u3067\u3042\u308bSciMed (Asia) Pte Ltd\u304c\u3001\u5225\u9014MaxCyte\u793e\u3068\u72ec\u5360\u8ca9\u58f2\u5951\u7d04\u3092\u7de0\u7d50\u3057\u30016\u6708\u306b\u540c\u56fd\u3067ExPERT\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306e\u8ca9\u58f2\u3092\u958b\u59cb\u3057\u305f\u3002 MaxCyte\u793e\u306f\u3001\u7d30\u80de\u5de5\u5b66\u306b\u6ce8\u529b\u3059\u308b\u30ea\u30fc\u30c7\u30a3\u30f3\u30b0\u30ab\u30f3\u30d1\u30cb\u30fc\u3067\u3042\u308a\u3001\u6b21\u4e16\u4ee3\u7d30\u80de\u6cbb\u7642\u85ac\u306e\u767a\u898b\u3001\u958b\u767a\u3001\u5546\u696d\u5316\u3092\u63a8\u9032\u3059\u308b\u305f\u3081\u306e\u57fa\u76e4\u6280\u8853\u3092\u63d0\u4f9b\u3057\u3066\u3044\u308b\u3002 \u672c\u63d0\u643a\u306b\u57fa\u3065\u304d\u3001PHCbi\u306fMaxCyte\u793e\u306e\u6a5f\u5668\u3001\u6d88\u8017\u54c1\u3001\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u306e\u8ca9\u58f2\u304a\u3088\u3073\u30b5\u30fc\u30d3\u30b9\u30b5\u30dd\u30fc\u30c8\u3092\u63d0\u4f9b\u3057\u3001\u7814\u7a76\u8005\u3084\u88fd\u9020\u696d\u8005\u306b\u5bfe\u3057\u3001\u81e8\u5e8a\u7684\u306b\u5b9f\u8a3c\u6e08\u307f\u306e\u975e\u30a6\u30a4\u30eb\u30b9\u6027\u7d30\u80de\u5de5\u5b66\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3078\u306e\u30a2\u30af\u30bb\u30b9\u3092\u63d0\u4f9b\u3059\u308b\u3002.<\/p>

MaxCyte\u793e\u306eExPERT\u88c5\u7f6e\u30e9\u30a4\u30f3\u30ca\u30c3\u30d7\u306f\u3001\u8907\u96d1\u304b\u3064\u30b9\u30b1\u30fc\u30e9\u30d6\u30eb\u306a\u7d30\u80de\u5de5\u5b66\u306b\u5411\u3051\u305f\u3001\u81e8\u5e8a\u7684\u304a\u3088\u3073\u5546\u696d\u7684\u306b\u5b9f\u8a3c\u6e08\u307f\u306e\u6b21\u4e16\u4ee3\u3092\u30ea\u30fc\u30c9\u3059\u308b\u30a8\u30ec\u30af\u30c8\u30ed\u30dd\u30ec\u30fc\u30b7\u30e7\u30f3\u6280\u8853\u3067\u3042\u308b\u3002\u9ad8\u3044\u30c8\u30e9\u30f3\u30b9\u30d5\u30a7\u30af\u30b7\u30e7\u30f3\u52b9\u7387\u3068\u7d30\u80de\u751f\u5b58\u7387\u3001\u30b7\u30fc\u30e0\u30ec\u30b9\u306a\u30b9\u30b1\u30fc\u30e9\u30d3\u30ea\u30c6\u30a3\u3001\u305d\u3057\u3066\u6a5f\u80fd\u6027\u306e\u5411\u4e0a\u3092\u5b9f\u73fe\u3059\u308b\u3053\u3068\u3067\u3001ExPERT\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u3001\u6b21\u4e16\u4ee3\u306e\u751f\u7269\u5b66\u7684\u30fb\u7d30\u80de\u6cbb\u7642\u85ac\u306e\u5b9f\u73fe\u306b\u4e0d\u53ef\u6b20\u306a\u30cf\u30a4\u30a8\u30f3\u30c9\u306a\u6027\u80fd\u3092\u63d0\u4f9b\u3059\u308b\u3002.<\/p>

PHCbi\u306f\u3001\u672c\u5951\u7d04\u306e\u5bfe\u8c61\u3068\u306a\u308bMaxCyte\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306e\u5168\u88fd\u54c1\u7fa4\uff08ExPERT ATx\u00ae\u3001ExPERT STx\u00ae\u3001ExPERT GTx\u00ae\u3001ExPERT VLx\u00ae\u306a\u3069\uff09\u304a\u3088\u3073\u3001\u51e6\u7406\u30a2\u30bb\u30f3\u30d6\u30ea\u3084\u30a8\u30ec\u30af\u30c8\u30ed\u30dd\u30ec\u30fc\u30b7\u30e7\u30f3\u30d0\u30c3\u30d5\u30a1\u30fc\u306a\u3069\u306e\u95a2\u9023\u6d88\u8017\u54c1\u3092\u8ca9\u58f2\u30fb\u30b5\u30dd\u30fc\u30c8\u3059\u308b\u3002 \u3053\u308c\u3089\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u4e16\u754c\u4e2d\u306e\u7814\u7a76\u8005\u306b\u3088\u3063\u3066\u5229\u7528\u3055\u308c\u3066\u304a\u308a\u30012025\u5e74\u7b2c1\u56db\u534a\u671f\u6642\u70b9\u306770\u4ef6\u4ee5\u4e0a\u306e\u81e8\u5e8a\u30d7\u30ed\u30b0\u30e9\u30e0\u3067\u63a1\u7528\u3055\u308c\u3066\u3044\u308b\u3002.<\/p>

\u3053\u3061\u3089\u3082\u304a\u8aad\u307f\u304f\u3060\u3055\u3044\uff1a PRD\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u304cPRD001\u306e\u6700\u521d\u306e\u30d2\u30c8\u81e8\u5e8a\u8a66\u9a13\u3092\u958b\u59cb<\/a><\/h4>

PHC\u682a\u5f0f\u4f1a\u793e\u306e\u53d6\u7de0\u5f79\u3067\u3042\u308a\u3001PHCbi\u306e\u30bc\u30cd\u30e9\u30eb\u30de\u30cd\u30fc\u30b8\u30e3\u30fc\u3092\u52d9\u3081\u308b\u9ad8\u5c3e \u529b\u6c0f\u306f\u6b21\u306e\u3088\u3046\u306b\u8ff0\u3079\u305f\u3002\u300c\u5f53\u793e\u306e\u7d30\u80de\u57f9\u990a\u6280\u8853\u30dd\u30fc\u30c8\u30d5\u30a9\u30ea\u30aa\u306b\u3001MaxCyte\u793e\u306eExPERT\u88c5\u7f6e\u3092\u52a0\u3048\u308b\u3053\u3068\u304c\u3067\u304d\u3001\u5b09\u3057\u304f\u601d\u3046\u3002 \u300e\u6cbb\u7642\u6cd5\u306e\u9032\u5316\u3068\u9032\u6b69\u306b\u8ca2\u732e\u3059\u308b\u300f\u3068\u3044\u3046\u30d3\u30b8\u30e7\u30f3\u3092\u6307\u91dd\u3068\u3057\u3066\u3001\u5f53\u793e\u306f\u7d30\u80de\u30fb\u907a\u4f1d\u5b50\u6cbb\u7642\uff08CGT\uff09\u306e\u88fd\u9020\u30d7\u30ed\u30bb\u30b9\u306b\u304a\u3051\u308bQCD\uff08\u54c1\u8cea\u3001\u30b3\u30b9\u30c8\u3001\u7d0d\u671f\uff09\u306e\u8ab2\u984c\u306b\u5bfe\u51e6\u3059\u308b\u65b0\u305f\u306a\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u306e\u62e1\u5145\u306b\u53d6\u308a\u7d44\u3093\u3067\u3044\u308b\u3002 MaxCyte\u793e\u306eExPERT\u88fd\u54c1\u7fa4\u306e\u8ffd\u52a0\u306b\u3088\u308a\u3001\u7d30\u80de\u30d9\u30fc\u30b9\u306e\u7814\u7a76\u958b\u767a\u30d7\u30ed\u30bb\u30b9\u3092\u63a8\u9032\u3057\u3001\u6700\u7d42\u7684\u306b\u306fCGT\u306e\u666e\u53ca\u3092\u52a0\u901f\u3055\u305b\u308b\u305f\u3081\u306e\u5f37\u529b\u306a\u975e\u30a6\u30a4\u30eb\u30b9\u6027\u30c4\u30fc\u30eb\u3092\u63d0\u4f9b\u3059\u308b\u3053\u3068\u3067\u3001\u79d1\u5b66\u8005\u3084\u7d30\u80de\u6cbb\u7642\u306e\u958b\u767a\u8005\u3092\u3088\u308a\u4e00\u5c64\u652f\u63f4\u3067\u304d\u308b\u3088\u3046\u306b\u306a\u308b\u3002\u300d\u201c<\/p>

MaxCyte\u793e\u306eExPERT\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306e\u5c0e\u5165\u306f\u3001\u7d30\u80de\u7642\u6cd5\uff08CGT\uff09\u306e\u958b\u767a\u304a\u3088\u3073\u88fd\u9020\u30d7\u30ed\u30bb\u30b9\u306e\u52b9\u7387\u3092\u3055\u3089\u306b\u9ad8\u3081\u3064\u3064\u3001\u7d30\u80de\u306e\u54c1\u8cea\u3068\u5b89\u5168\u6027\u3092\u5411\u4e0a\u3055\u305b\u308b\u3068\u3044\u3046PHCbi\u306e\u7d99\u7d9a\u7684\u306a\u53d6\u308a\u7d44\u307f\u3092\u88dc\u5b8c\u3059\u308b\u3082\u306e\u3067\u3042\u308b\u3002PHCbi\u306f\u6700\u8fd1\u3001\u7814\u7a76\u7528\u3068\u3057\u3066LiCellMo\u2122\u751f\u7d30\u80de\u4ee3\u8b1d\u5206\u6790\u88c5\u7f6e\u3092\u767a\u58f2\u3057\u305f\u3002\u540c\u88c5\u7f6e\u306b\u306f PHC<\/a>\u2019\u306e\u4e2d\u6838\u3068\u306a\u308b\u30a4\u30f3\u30e9\u30a4\u30f3\u30e2\u30cb\u30bf\u30ea\u30f3\u30b0\u6280\u8853\u3060\u3002\u3055\u3089\u306b\u3001PHCbi\u306f\u300cLiCellGrowTM\u300d\u7d30\u80de\u5897\u6b96\u30b7\u30b9\u30c6\u30e0\u3092\u958b\u767a\u4e2d\u3067\u3042\u308a\u3001\u3053\u308c\u306f\u7d30\u80de\u306e\u4ee3\u8b1d\u72b6\u614b\u306b\u57fa\u3065\u3044\u3066\u57f9\u5730\u3092\u81ea\u52d5\u7684\u306b\u4ea4\u63db\u3059\u308b\u3053\u3068\u3067\u3001\u7d30\u80de\u57f9\u990a\u74b0\u5883\u3092\u6700\u9069\u5316\u3059\u308b\u3088\u3046\u306b\u8a2d\u8a08\u3055\u308c\u3066\u3044\u308b\u3002\u3053\u308c\u306b\u52a0\u3048\u3001 MaxCyte<\/a>\u2019\u540c\u793e\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306b\u304a\u3044\u3066\u3001\u3053\u308c\u3089\u306e\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u306f\u3001\u518d\u751f\u533b\u7642\u3001\u514d\u75ab\u7642\u6cd5\u3001\u30d0\u30a4\u30aa\u751f\u7523\u306a\u3069\u306e\u5206\u91ce\u3067\u6d3b\u52d5\u3059\u308b\u7814\u7a76\u8005\u3084\u958b\u767a\u8005\u306b\u5bfe\u3057\u3066\u5305\u62ec\u7684\u306a\u652f\u63f4\u3092\u63d0\u4f9b\u3059\u308b\u3068\u3068\u3082\u306b\u3001\u65e5\u672c\u304a\u3088\u3073\u30b7\u30f3\u30ac\u30dd\u30fc\u30eb\u306b\u304a\u3051\u308b\u7d30\u80de\u3092\u7528\u3044\u305f\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u3092\u52a0\u901f\u3055\u305b\u308b\u3068\u3044\u3046PHCbi\u306e\u53d6\u308a\u7d44\u307f\u3092\u53cd\u6620\u3057\u3066\u3044\u308b\u3002.<\/p>

\u30bd\u30fc\u30b9 BusinessWire<\/a><\/strong><\/p>","protected":false},"excerpt":{"rendered":"

The Biomedical Division of PHC Corporation, a subsidiary of PHC Holdings Corporation announces it has signed an exclusive agreement with MaxCyte, Inc. to distribute the MaxCyte ExPERT platform in Japan. In Singapore, SciMed (Asia) Pte Ltd, a subsidiary of PHCHD, separately entered into an exclusive distribution agreement with MaxCyte and launched the ExPERT platform in the country in June. MaxCyte is a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics. Under this partnership, PHCbi will offer sales and service support for MaxCyte’s instruments, consumables, and solutions, providing researchers and manufacturers with access to a clinically proven, non-viral cell engineering […]<\/p>\n","protected":false},"author":4,"featured_media":16909,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"wprm-recipe-roundup-name":"","wprm-recipe-roundup-description":"","postBodyCss":"","postBodyMargin":[],"postBodyPadding":[],"postBodyBackground":{"backgroundType":"classic","gradient":""},"footnotes":""},"categories":[208,89,211,237,182,206],"tags":[5778,5777,5780,424,5779,5781],"ppma_author":[205],"class_list":["post-16858","post","type-post","status-publish","format-standard","has-post-thumbnail","category-apac","category-health-tech","category-japan","category-news","category-pharma","category-regional","tag-biomanufacturing","tag-expert-platform","tag-maxcyte","tag-pharma","tag-phc-holdings-corporation","tag-phcbi"],"yoast_head":"\nPHC to Distribute MaxCyte ExPERT Platform in Japan<\/title>\n<meta name=\"description\" content=\"PHCbi signs deal to distribute MaxCyte ExPERT platform in Japan, offering advanced non-viral cell engineering support to researchers.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/phc-secures-exclusive-rights-to-maxcyte-expert-in-japan\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PHC to Distribute MaxCyte ExPERT Platform in Japan\" \/>\n<meta property=\"og:description\" content=\"PHCbi signs deal to distribute MaxCyte ExPERT platform in Japan, offering advanced non-viral cell engineering support to researchers.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/phc-secures-exclusive-rights-to-maxcyte-expert-in-japan\/\" \/>\n<meta property=\"og:site_name\" content=\"itbusinesstoday\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-01T10:45:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/07\/PHC-Announces-Exclusive-Distribution-of-MaxCyte\u00ae-ExPERT\u2122-Platform-in-Japan.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"NewsDesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"NewsDesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"2\u5206\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"PHC\u3001MaxCyte ExPERT\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3092\u65e5\u672c\u3067\u8ca9\u58f2\u958b\u59cb","description":"PHCbi\u793e\u3001MaxCyte ExPERT\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306e\u65e5\u672c\u306b\u304a\u3051\u308b\u8ca9\u58f2\u5951\u7d04\u3092\u7de0\u7d50\u3002.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/phc-secures-exclusive-rights-to-maxcyte-expert-in-japan\/","og_locale":"ja_JP","og_type":"article","og_title":"PHC to Distribute MaxCyte ExPERT Platform in Japan","og_description":"PHCbi signs deal to distribute MaxCyte ExPERT platform in Japan, offering advanced non-viral cell engineering support to researchers.","og_url":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/phc-secures-exclusive-rights-to-maxcyte-expert-in-japan\/","og_site_name":"itbusinesstoday","article_published_time":"2025-07-01T10:45:48+00:00","og_image":[{"width":1200,"height":800,"url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/07\/PHC-Announces-Exclusive-Distribution-of-MaxCyte\u00ae-ExPERT\u2122-Platform-in-Japan.webp","type":"image\/webp"}],"author":"NewsDesk","twitter_card":"summary_large_image","twitter_misc":{"\u57f7\u7b46\u8005":"NewsDesk","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"2\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/phc-secures-exclusive-rights-to-maxcyte-expert-in-japan\/#article","isPartOf":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/phc-secures-exclusive-rights-to-maxcyte-expert-in-japan\/"},"author":{"name":"NewsDesk","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/person\/d58d81f55e8acd257ab63d49fb4ea812"},"headline":"PHC secures exclusive rights to MaxCyte ExPERT in Japan","datePublished":"2025-07-01T10:45:48+00:00","mainEntityOfPage":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/phc-secures-exclusive-rights-to-maxcyte-expert-in-japan\/"},"wordCount":470,"publisher":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization"},"image":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/phc-secures-exclusive-rights-to-maxcyte-expert-in-japan\/#primaryimage"},"thumbnailUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/07\/PHC-Announces-Exclusive-Distribution-of-MaxCyte\u00ae-ExPERT\u2122-Platform-in-Japan.webp","keywords":["Biomanufacturing","ExPERT platform","MaxCyte","Pharma","PHC Holdings Corporation","PHCbi"],"articleSection":["APAC","Health Tech","Japan","News","Pharma","Regional"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/phc-secures-exclusive-rights-to-maxcyte-expert-in-japan\/","url":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/phc-secures-exclusive-rights-to-maxcyte-expert-in-japan\/","name":"PHC\u3001MaxCyte ExPERT\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3092\u65e5\u672c\u3067\u8ca9\u58f2\u958b\u59cb","isPartOf":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#website"},"primaryImageOfPage":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/phc-secures-exclusive-rights-to-maxcyte-expert-in-japan\/#primaryimage"},"image":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/phc-secures-exclusive-rights-to-maxcyte-expert-in-japan\/#primaryimage"},"thumbnailUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/07\/PHC-Announces-Exclusive-Distribution-of-MaxCyte\u00ae-ExPERT\u2122-Platform-in-Japan.webp","datePublished":"2025-07-01T10:45:48+00:00","description":"PHCbi\u793e\u3001MaxCyte ExPERT\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306e\u65e5\u672c\u306b\u304a\u3051\u308b\u8ca9\u58f2\u5951\u7d04\u3092\u7de0\u7d50\u3002.","breadcrumb":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/phc-secures-exclusive-rights-to-maxcyte-expert-in-japan\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/itbusinesstoday.com\/health-tech\/pharma\/phc-secures-exclusive-rights-to-maxcyte-expert-in-japan\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/phc-secures-exclusive-rights-to-maxcyte-expert-in-japan\/#primaryimage","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/07\/PHC-Announces-Exclusive-Distribution-of-MaxCyte\u00ae-ExPERT\u2122-Platform-in-Japan.webp","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/07\/PHC-Announces-Exclusive-Distribution-of-MaxCyte\u00ae-ExPERT\u2122-Platform-in-Japan.webp","width":1200,"height":800,"caption":"PHC"},{"@type":"BreadcrumbList","@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/phc-secures-exclusive-rights-to-maxcyte-expert-in-japan\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/itbusinesstoday.com\/"},{"@type":"ListItem","position":2,"name":"PHC secures exclusive rights to MaxCyte ExPERT in Japan"}]},{"@type":"WebSite","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#website","url":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","description":"","publisher":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","url":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/logo\/image\/","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Asset-1.png","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Asset-1.png","width":663,"height":275,"caption":"itbusinesstoday"},"image":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/person\/d58d81f55e8acd257ab63d49fb4ea812","name":"\u30cb\u30e5\u30fc\u30b9\u30c7\u30b9\u30af","image":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/it.png74f313ad3d6fa27a1eee85c30be63d03","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/it.png","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/it.png","caption":"NewsDesk"},"sameAs":["https:\/\/itbusinesstoday.com"],"url":"https:\/\/itbusinesstoday.com\/ja\/author\/newsdesk\/"}]}},"authors":[{"term_id":205,"user_id":4,"is_guest":0,"slug":"newsdesk","display_name":"NewsDesk","avatar_url":{"url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/it.png","url2x":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/it.png"},"author_category":"","first_name":"NewsDesk","last_name":"","user_url":"https:\/\/itbusinesstoday.com","job_title":"","description":""}],"_links":{"self":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/16858","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/comments?post=16858"}],"version-history":[{"count":1,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/16858\/revisions"}],"predecessor-version":[{"id":16859,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/16858\/revisions\/16859"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media\/16909"}],"wp:attachment":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media?parent=16858"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/categories?post=16858"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/tags?post=16858"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/ppma_author?post=16858"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}